|
NFU1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.851700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.257000E-01 |
| Normal-vs-Stage2 |
6.102800E-01 |
| Normal-vs-Stage3 |
1.303820E-03 |
| Normal-vs-Stage4 |
1.321700E-03 |
| Stage1-vs-Stage2 |
9.923400E-01 |
| Stage1-vs-Stage3 |
1.135700E-03 |
| Stage1-vs-Stage4 |
3.397700E-03 |
| Stage2-vs-Stage3 |
3.424200E-02 |
| Stage2-vs-Stage4 |
5.029900E-02 |
| Stage3-vs-Stage4 |
9.658200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.086300E-02 |
| Normal-vs-AfricanAmerican |
6.922400E-03 |
| Normal-vs-Asian |
4.165600E-01 |
| Caucasian-vs-AfricanAmerican |
1.630390E-01 |
| Caucasian-vs-Asian |
9.390200E-01 |
| AfricanAmerican-vs-Asian |
6.224400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.800100E-03 |
| Normal-vs-Female |
4.244400E-01 |
| Male-vs-Female |
2.145600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.120500E-02 |
| Normal-vs-Age(41-60Yrs) |
3.299600E-02 |
| Normal-vs-Age(61-80Yrs) |
8.938100E-02 |
| Normal-vs-Age(81-100Yrs) |
2.457200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.209800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.937800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.384400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.741200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.794600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.357800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.816000E-01 |
| Normal-vs-Grade 2 |
8.295800E-01 |
| Normal-vs-Grade 3 |
3.140300E-02 |
| Normal-vs-Grade 4 |
1.76649999961143E-07 |
| Grade 1-vs-Grade 2 |
3.105400E-01 |
| Grade 1-vs-Grade 3 |
4.916400E-01 |
| Grade 1-vs-Grade 4 |
3.600400E-04 |
| Grade 2-vs-Grade 3 |
1.522390E-02 |
| Grade 2-vs-Grade 4 |
3.92520005387809E-09 |
| Grade 3-vs-Grade 4 |
1.048520E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.569540E-02 |
| Normal-vs-ccB subtype |
3.68270003381355E-09 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.775700E-02 |
| Normal-vs-N1 |
8.0992000000002E-05 |
| N0-vs-N1 |
6.415200E-04 |
|
|
